Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,031 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

CLL Therapy Approaches in Russia

NCT05140369

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Belgorod, Russia
  • Research Site Bryansk, Russia
  • Research Site Chelyabinsk, Russia
  • Research Site Chita, Russia
View all 34 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma

NCT05646836

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Peter Maccallum Cancer Centre Melbourne, Victoria, Australia
  • Alfred Hospital Melbourne, Victoria, Australia
  • Sygehus Lillebaelt - Vejle Sygehus Vejle, Denmark
View all 13 locations
View Trial Details
Active, Not Recruiting

Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by Surgery

NCT02160015

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Active, Not Recruiting

Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment

NCT05627245

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +24 more
Locations
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Kansas Clinical Research Center Fairway, Kansas, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
View Trial Details
Active, Not Recruiting

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

NCT04067336

Conditions
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +20 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UCLA Ronald Reagan Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, Illinois, United States
View all 43 locations
View Trial Details

Related conditions